USE OF A HIV DERIVED ACCESSORY PROTEIN FOR THE REACTIVATION OF LATENT HIV

摘要

The present invention concerns the use of a protein comprising at least a HIV-derived accessory protein tat (trans-activator of transcription) or any derivative thereof for the reactivation of latent human immunodeficiency virus (HIV) from cells present in a HIV-infected patient.